Novartis Bioventures Ltd sold $1.8M of Ra Pharmaceuticals, Inc.

10% owner

Sold$1,773,164

$20.96Price

84,615Shares

−3%Stake

What RARX did after the filing

Prices for RARX after this filing aren't in yet.

Traded Wed, Feb 22. Filed Tue, May 2, 1:22 PM ET, during the session. Not investment advice.